Skip to main navigation Skip to search Skip to main content

The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

  • Haitao Yang
  • , Maojun Yang
  • , Yi Ding
  • , Yiwei Liu
  • , Zhiyong Lou
  • , Zhe Zhou
  • , Lei Sun
  • , Lijuan Mo
  • , Sheng Ye
  • , Hai Pang
  • , George F. Gao
  • , Kanchan Anand
  • , Mark Bartlam
  • , Rolf Hilgenfeld
  • , Zihe Rao*
  • *Corresponding author for this work
  • Tsinghua University
  • University of Lübeck

Research output: Contribution to journalArticlepeer-review

Abstract

A newly identified severe acute respiratory syndrome coronavirus (SARS-CoV), is the etiological agent responsible for the outbreak of SARS. The SARS-CoV main protease, which is a 33.8-kDa protease (also called the 3C-like protease), plays a pivotal role in mediating viral replication and transcription functions through extensive proteolytic processing of two replicase polyproteins, pp1a (486 kDa) and pp1ab (790 kDa). Here, we report the crystal structures of the SARS-CoV main protease at different pH values and in complex with a specific inhibitor. The protease structure has a fold that can be described as an augmented serine-protease, but with a Cys-His at the active site. This series of crystal structures, which is the first, to our knowledge, of any protein from the SARS virus, reveal substantial pH-dependent conformational changes, and an unexpected mode of inhibitor binding, providing a structural basis for rational drug design.

Original languageEnglish
Pages (from-to)13190-13195
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume100
Issue number23
DOIs
StatePublished - 11 Nov 2003
Externally publishedYes

Fingerprint

Dive into the research topics of 'The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor'. Together they form a unique fingerprint.

Cite this